Categories: HealthcareNews

Stryker to announce financial results for its fourth quarter and full year 2023

Portage, Michigan, Jan. 05, 2024 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker – Press Releases that day. The press release will include summary financial information for the company’s fourth quarter and full year 2023, that ended December 31, 2023.

Stryker will host a webcast at 4:30pm ET on Tuesday, January 30, 2024, to discuss results for its fourth quarter and full year 2023.  The webcast can be accessed at Stryker – Events & Presentations.  An archive of the webcast will also be available on the company’s website two hours after the live call ends.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries please contact:
Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com 

For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com

Staff

Recent Posts

Coloplast announces changes to Executive Leadership Team

Today, Coloplast is announcing changes to the company’s Executive Leadership Team (ELT). The changes relate…

44 minutes ago

Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference

- The overview presentation will review some of the Company’s recent achievements as well as…

44 minutes ago

ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK

Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future…

45 minutes ago

TOMI Environmental Solutions Secures a Purchase Order of Approximately $500,000 for the Integration of SteraMist iHP Technology within a Global Biopharmaceutical Leader

FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ),…

45 minutes ago

Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

BOCA RATON, FLA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT)…

45 minutes ago

Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…

45 minutes ago